# Congruence Therapeutics: Research, Montreal, Canada

> Congruence Therapeutics: Congruence Therapeutics is a Montreal-based biotechnology company founded in 2021 by Clarissa Desjardins, PhD, and Michael Rock...

Source: https://millionrounds.com/startup/congruence-therapeutics (Millionrounds; every figure on the page links to its filing or article)

Canada · [Research startup](https://millionrounds.com/companies)

# Congruence Therapeutics

Congruence Therapeutics is a Montreal-based biotechnology company founded in 2021 by Clarissa Desjardins, PhD, and Michael Rock Goldsmith.

Funding reported Last round: Series A

Research Montreal, Canada

Company summary

- **Founded:** 2021 5 years old
- **Team:** 43 11 to 50 people
- **Funding reported:** 64.6M as listed, currency not stated
- **Last round:** Series A Mar 2023

How sure we are

- ✓ **Listed** We know it exists and what it does
- 2 **Funding reported** A company dataset reports a raise
- 3 **Observed** A filing or a dated announcement confirms a round

No round for Congruence Therapeutics has been confirmed by a filing or an announcement yet, so nothing here counts toward an investor's record. [How we decide](https://millionrounds.com/methodology)

## About Congruence Therapeutics

Congruence Therapeutics is a Montreal-based biotechnology company founded in 2021 by Clarissa Desjardins, PhD, and Michael Rock Goldsmith.

The company specializes in computational and experimental drug discovery, focusing on designing small-molecule pharmacological stabilizers for diseases caused by protein misfolding. Congruence Therapeutics aims to address rare diseases and severe genetic conditions that currently lack effective treatments. The company utilizes advanced techniques in protein dynamics, biophysics, machine learning, and computational chemistry through its in silico platform. This platform enables the rapid design of validated small molecules, bridging computational modeling with experimental validation. Congruence's flagship innovation, the RevenirTM Product Engine, captures biophysical features of proteins and identifies novel pockets for drug targeting, facilitating the development of therapies for previously untreatable conditions. With approximately $139.5 million in funding and a growing workforce, Congruence Therapeutics is positioned for continued growth in the drug discovery sector.

## What company datasets say Congruence Therapeutics raised

Funding, as reported

Reported in all **64.6M** in the source's currency

Rounds **2**

Last round **Series A**

Last round size **39.5M**

Last round date **Mar 2023**

Investors listed **10**

## The company, in detail

What they build

Known for

protein conformations protein motion modeling health care revenir product engine predictive models biotechnology research protein misfolding medical research information technology & services mutation-induced biophysical changes protein ensemble modeling in silico drug design hospital & health care medical ensemble of conformers biophysical descriptors

Built with from their website

Yoast SEO WordPress.org Font Awesome Google Workspace Viewport Meta Barracuda Email Security Service Yoast Element UI Barracuda Networks WP Engine

+8 more

Vimeo GoDaddy Domains Akismet Wordpress Microsoft Exchange Online Apple Business Manager Gravity Forms Google Cloud Hosting

- **Sector:** Research
- **Industry code:** NAICS 541714, SIC 2834
- **Region:** Quebec
- **Revenue:** 450k a year, as listed
- **Full record:** [Every detail in the company directory](https://millionrounds.com/directory/congruence-therapeutics)

## Research in Canada

Startups like it

- [**Altis Labs** Toronto · founded 2019 *Raised*](https://millionrounds.com/company/altis-labs)
- [**Sitka Biopharma** Vancouver · founded 2013 *Raised*](https://millionrounds.com/company/sitka-biopharma)
- [**ServiceNow AI Research** Montreal · founded 2016](https://millionrounds.com/startup/servicenow-ai-research)
- [**DalCor Pharmaceuticals** Montreal · founded 2015](https://millionrounds.com/startup/dalcor-pharmaceuticals)
- [**Notch Therapeutics** Vancouver · founded 2018](https://millionrounds.com/startup/notch-therapeutics)
- [**chemical.ai** Toronto · founded 2018](https://millionrounds.com/startup/chemical-ai)
- [**Zucara Therapeutics Inc.** Toronto · founded 2015](https://millionrounds.com/startup/zucara-therapeutics-inc)
- [**Nomic Bio** Montreal · founded 2017](https://millionrounds.com/startup/nomic-bio)

## Is this your company?

Add your raise, your deck and your story, and put Congruence Therapeutics in front of investors. Or tell us what we have wrong.

[List your startup](https://millionrounds.com/list-your-startup)[Send a correction](https://millionrounds.com/corrections)